ARX vs PAR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

PAR

PARA BIO FPO [PAR]

48LOW

Score Breakdown

ARX PAR
Technical
38
53
Catalyst
50
51
Sentiment
50
50
Fundamental
95
60
Momentum
55
42
Risk Gate
50
50

Key Metrics

ARX Metric PAR
$202.9MMarket Cap$99.4M
314KAvg Volume (20d)2.2M
N/AShort InterestN/A
$0.80052-Week High$0.470
$0.49552-Week Low$0.135
-0.8%Daily Change-7.4%
$0.580Reference Price$0.162
+4.9%ROE-180.2%
+4.5%Profit MarginN/A

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.6x) on a red day — sellers in control
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.0x)

PAR Signals

RSI drifting toward oversold territory — worth watching
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Drifting lower — down 4.7% over the last 5 days
Volatility is contracting — like a spring being compressed, breakouts often follow
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk
Very high P/S ratio (11766.1x)
Strong revenue growth (+51%)

Ask Scout AI to compare ARX and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs SPL →ATH vs EIQ →ATH vs ENP →ATH vs IBX →ATH vs IMU →
ARX Full Analysis → PAR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).